Asia Pacific Blister Packaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Asia-Pacific Blister Packaging Market is expected to register a CAGR of 6.5% during the forecast period 2021-2026. The outbreak of new diseases, growth in regulatory norms, focus on population health management, inventions, more informed customers, and growth in OTC drugs, have augmented the growth of blister packaging in the region.

• Increasing pressure on pharmaceutical companies to manufacture more medicines to be made available for patients, owing to a rise in diseases and stringent governmental regulations against counterfeit drugs, are among the major factors propelling the market.
• Moreover, factors like product integrity and extended shelf life are highly necessary for the pharmaceutical sector, considering that most consumers store their drugs in a temperature variant atmosphere that can be harmful to unprotected medicines.
• There is also a growing demand for pharmaceutical and personal care products in the region where considerable consumer expenditure is increasing for both pharmaceutical and personal care products. Products, such as capsules, lozenges, sterile products, and liquid cosmetics like perfumes
• In the pharmaceutical industry, blister packaging offers a wide range of solutions: among these are PVC, PCTFE, PVDC, and thermoform blisters for less sensitive products or Alu-Alu cold form blisters for Active Pharmaceutical Ingredients (APIs) that are more sensitive. However, unsuitability for heavy items coupled with stringent regulation in developing countries is anticipated to restrain the market growth.
• The outbreak of Covid-19 has boosted the demand for blister packaging in the region as demand from the pharmaceutical industry rose dramatically. For Instance, India will export 285 million tablets of anti-malaria drug hydroxychloroquine (HCQ) to 40 countries and 500 million tablets of paracetamol to 60 countries to fight Covid-19.

Key Market Trends

Pharmaceutical and Healthcare Sector to Account for a Major Share

• The Asia Pacific is the third-largest pharmaceutical market in the world after North America and Europe. The healthcare and pharmaceutical sector poses a different set of demands for the blister packaging solutions, regarding insulation from external surroundings, high levels of protection, cost-effectiveness, and ease of handling.
• When drugs are packaged in blisters, adherence is improved because consumers can keep track of their medications and dosing. Moreover, the unit dosage feature of blisters reduces the risk of incorrect dosing.
• The retail-level preparation of prescription drugs is troubling pharmacists or pharmaceutical technicians. The administration of medicines in the open atmosphere of the supermarket and drug store can negatively affect sensitive drugs when they are transferred from container to container. Blister packaging can ensure the process of distribution directly to the customer.
• Protecting product integrity remains the primary goal of pharmaceutical healthcare packaging. Still, as in all areas of the packaging industry, there is continued work on cost reduction in the packaging process. Moreover, blister packed medicines can prove to be very helpful for the transportation of medicines over long distances.

China to Hold a Significant Share

• The pharmaceutical and healthcare industry holds the dominant share of the blister packaging market in the region, particularly China, as China is the world's one of the largest pharmaceutical market and a strategic priority for most global players. The country is the largest producer of an active pharmaceutical ingredient in the world. The consumer goods sector is also expected to contribute a significant market share over the forecast period.
• According to the China Chamber of Commerce, in 2019, China exported 10.12 million tonnes of APIs, up 8.83% year-on-year. China exports APIs to 189 countries and regions, mainly in Asia, Europe, and North America.
• Blister packaging also provides the possibility to create a compliance pack or calendar pack by labeling the prescription, to which patients can easily adhere. Further, China's massive investments in building up the pipeline of medicines and future drugs can be perceived as an excellent opportunity for the growth of blister packaging in the country.

Competitive Landscape

The Asia-Pacific blister packaging market is moderately concentrated. Some of the key players in the market include Uflex Limited, Amcor Flexible India Pvt Ltd., and Getpac India. Players in the market adopt multiple strategic initiatives such as partnerships, joint ventures, and mergers and acquisitions to grow and compete. Some of the recent developments are:

• In January 2020 - Amcor partnered with Moda to offer innovative packaging solutions. Amcor and Moda offer multiple innovative solutions in flexible packaging and are expected to provide new resources to help gain and further strengthen Amcor’s position in the flexible packaging market.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.